missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human sFRP-4 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marca: R&D Systems™ 1827-SF-025
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The Recombinant Human sFRP-4 Protein is derived from NS0. The Recombinant Human sFRP-4 Protein has been validated for the following applications: Bioactivity.Especificaciones
| Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
| 38.9 kDa | |
| 25 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 6424 | |
| sFRP-4 | |
| Mouse myeloma cell line,NS0-derived human sFRP-4 protein Ala22-Val346,with a C-terminal 10-His tag | |
| Recombinant Human sFRP-4 is prone to proteolytic cleavage at C-terminus, therefore the poly-His tag at C-terminus may not be present in the preparation. | |
| Recombinant |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido